A C. elegans genome-wide RNAi screen for altered levamisole sensitivity identifies genes required for muscle function

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• The neuromuscular junction (NMJ) is crucial for muscle contraction, relying on postsynaptic ionotropic acetylcholine receptors (AChRs).
• Understanding regulators of postsynaptic function is vital for addressing neuromuscular disorders.

Purpose of the Study:

• To identify genes regulating postsynaptic function at the Caenorhabditis elegans NMJ using a genome-wide RNAi screen.
• To investigate the role of specific genes, including Epsin homolog epn-1 and gas-1, in response to levamisole, an L-AChR agonist.

Main Methods:

• Genome-wide RNAi screen in C. elegans to identify genes affecting levamisole response.
• Phenotypic analysis of gene knockdowns for levamisole hypersensitivity and resistance.
• Investigation of gene functions related to receptor endocytosis and mitochondrial respiration.

Main Results:

• 117 gene knockdowns caused levamisole hypersensitivity; 18 caused resistance.
• Identified conserved genes linked to human congenital myopathies and myasthenic syndromes.
• Loss of epn-1 altered L-AChR and GABAA receptor levels; gas-1 knockdown affected mitochondrial Complex I.
• Levamisole treatment depleted ATP levels in a L-AChR-dependent manner.

Conclusions:

• The screen identified novel regulators of postsynaptic function at the NMJ.
• Findings implicate Epsin and mitochondrial function in L-AChR regulation and neuromuscular disorders.
• Levamisole's paralytic effects may lead to metabolic exhaustion via ATP depletion.